IMS works with a variety of media outlets and trade associations to share expertise on issues impacting the pharmaceutical industry. This section provides abstracts and PDFs of current published articles, as well as extracts from recent industry presentations.

Page: <<  1  2  3  4  5  6  7  8  9  10   >>

Just What (and Why and When) the Doctor Ordered: Understanding Is Enhanced with Longitudinal Data
This IMS report in Product Management Today re-introduces the phase "getting a foot in the door."  IMS's Ron Brand and Michel Denarié discuss why incorporating longitudinal data in segmentation techniques will help understand physicians' needs and drive messaging and detail strategies, which can strengthen physician relationships and drive sales.
Oct 18, 2004

Developing a Patient-Based Forecast Model to Help Drive Marketing Strategy
Dynamic forecast models can provide important input into organizational priorities, budgets, and individual product strategies.
Oct 1, 2004

DTC at the Crossroads: A "Direct" Hit or Miss?
DTC is a key component of many promotional strategies, but does it deliver positive returns?  IMS offers the definitive answer to this question with the industry’s most recent and comprehensive study of DTC effectiveness.
Sep 23, 2004

Pricing Climate Heats Up in U.S. and Europe
This IMS Pricing and Reimbursement Report discusses the decline of new molecular entities in both the US and Europe. IMS Consulting and Cambridge Pharma Consulting discuss the highs and lows from cost-containment to pricing and reimbursement for 2003.
Sep 3, 2004

The Future of Price Regulation in the U.S. Pharmaceutical Market
Over the past few years, the battleground on pharmaceutical prices in the US has focused on importation - highly emotional issue for both consumers and politicians.
Sep 1, 2004

A $20 Billion Bill and Plenty of Change
This article featured in Pharmaceutical Executive details the pharmaceutical industry's marketing spend and promotion trends.
Sep 1, 2004

Using Anonymous Patient-Level Data to Develop and Prioritize Segments: An Example From the Hyperlipidemia Markets
Pharmaceutical marketers know that effective marketing strategies include the concept of segmentation.
Sep 1, 2004

Bruised but Triumphant
This IMS Health Report discusses how the pharma industry, despite getting battered in several arenas in 2003, emerged with its record of continued success firmly intact.
Aug 18, 2004

Anonymous Patient-Level Data and the New Paradigm of Disease: The Metabolic Syndrome Example
An increasing attention is being paid to "constellation illnesses," pharmaceutical marketers are wondering how to adapt their market research and marketing practices to this new paradigm.
Aug 1, 2004

Innovative Measures of Brand Opportunity and Performance
An increasing attention is being paid to "constellation illnesses," pharmaceutical marketers are wondering how to adapt their market research and marketing practices to this new paradigm.
Jul 1, 2004

Page: <<  1  2  3  4  5  6  7  8  9  10   >>

Home | Contact | Search | Site Map | FAQ | Privacy | Websites
Copyright © 2007 IMS Health Incorporated. All rights reserved.